We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
-3.12%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$19.3B
AUM Growth
-$1.05B
(-5.2%)
Cap. Flow
-$77.1M
Cap. Flow
% of AUM
-0.4%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
1,444
New
138
Increased
405
Reduced
531
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$224M |
| 2 |
Brown-Forman Class B
BF.B
|
+$140M |
| 3 |
UnitedHealth
UNH
|
+$132M |
| 4 |
Monolithic Power Systems
MPWR
|
+$108M |
| 5 |
Oracle
ORCL
|
+$97.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$134M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 3 |
Micron Technology
MU
|
+$122M |
| 4 |
Pfizer
PFE
|
+$120M |
| 5 |
Microsoft
MSFT
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.43% |
| 2 | Healthcare | 14.49% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.92% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Cathay General Bancorp
CATY
$4.31B
| $1.24M | 0.01% |
32,150
-12,734
| -28% | -$530K |
|
627
eGain
EGAN
$205M
| $1.23M | 0.01% |
167,535
+22,004
| +15% | +$198K |
|
628
Vir Biotechnology
VIR
$1.53B
| $1.23M | 0.01% |
63,874
+48,414
| +313% | +$1.23M |
|
|
VBTX
629
DELISTED
Veritex Holdings
VBTX
| $1.23M | 0.01% |
46,169
-2,300
| -5% | -$69.6K |
|
630
Inspire Medical Systems
INSP
$1.69B
| $1.22M | 0.01% |
6,901
+422
| +7% | +$84.8K |
|
631
Alnylam Pharmaceuticals
ALNY
$30.2B
| $1.22M | 0.01% |
+6,112
| New | +$1.17M |
|
632
Esquire Financial Holdings
ESQ
$1.6B
| $1.22M | 0.01% |
32,530
+17,948
| +123% | +$668K |
|
|
CPE
633
DELISTED
Callon Petroleum Company
CPE
| $1.22M | 0.01% |
34,871
+8,465
| +32% | +$338K |
|
634
MSCI
MSCI
$42.1B
| $1.22M | 0.01% |
2,893
-3,435
| -54% | -$1.57M |
|
635
Ecolab
ECL
$77.4B
| $1.21M | 0.01% |
8,401
-20,443
| -71% | -$3.32M |
|
636
O'Reilly Automotive
ORLY
$75B
| $1.21M | 0.01% |
25,755
-2,025
| -7% | -$94.4K |
|
|
PZN
637
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $1.21M | 0.01% |
127,267
-7,080
| -5% | -$62.2K |
|
638
Talos Energy
TALO
$2.56B
| $1.2M | 0.01% |
72,342
-2,015
| -3% | -$36.1K |
|
639
GXO Logistics
GXO
$5.54B
| $1.2M | 0.01% |
34,161
-105
| -0.3% | -$4.64K |
|
640
Armstrong World Industries
AWI
$7.7B
| $1.2M | 0.01% |
+15,101
| New | +$1.28M |
|
641
Douglas Elliman
DOUG
$178M
| $1.2M | 0.01% |
306,147
-6,512
| -2% | -$32.2K |
|
642
Lakeland Financial Corp
LKFN
$1.56B
| $1.19M | 0.01% |
16,346
+7,710
| +89% | +$575K |
|
643
Home BancShares
HOMB
$6.26B
| $1.18M | 0.01% |
52,350
-2,600
| -5% | -$60.4K |
|
644
Prestige Consumer Healthcare
PBH
$2.42B
| $1.18M | 0.01% |
23,623
-6,863
| -23% | -$380K |
|
645
Tractor Supply
TSCO
$18.8B
| $1.17M | 0.01% |
31,535
+7,645
| +32% | +$298K |
|
646
Church & Dwight Co
CHD
$24.1B
| $1.16M | 0.01% |
16,253
| – | – |
|
|
CWEN.A
647
DELISTED
Clearway Energy Class A
CWEN.A
| $1.16M | 0.01% |
39,912
+23,537
| +144% | +$799K |
|
648
Clean Harbors
CLH
$16.8B
| $1.15M | 0.01% |
10,466
-1,725
| -14% | -$185K |
|
649
Ocular Therapeutix
OCUL
$2.23B
| $1.15M | 0.01% |
275,984
| – | – |
|
|
DQ
650
Daqo New Energy
DQ
$1B
| $1.14M | 0.01% |
21,519
-159,585
| -88% | -$10.2M |
|
Similar funds
FDCDDQ
WP
N
PCH
VAI
Los Angeles Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Los Angeles Capital Management held 1,444 positions worth $19.3B, down 5.2% from $20.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Los Angeles Capital Management's Q3 2022 filing shows 138 new, 405 increased, 531 reduced and 234 closed positions. Its largest new stake was Neurocrine Biosciences: 791,966 shares worth $84.1M. The largest sale was Alphabet (Google) Class C, an estimated $134M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- Los Angeles Capital Management's largest Q3 2022 buy was Neurocrine Biosciences: 791,966 shares worth $84.1M.
- Los Angeles Capital Management added most to Broadcom in Q3 2022, an estimated $224M increase.
- Los Angeles Capital Management's biggest Q3 2022 reduction was Alphabet (Google) Class C, cutting an estimated $134M.
- Los Angeles Capital Management fully exited D.R. Horton in Q3 2022, selling an estimated $37.1M.
- Los Angeles Capital Management's ten largest holdings make up 26% of its $19.3B portfolio in Q3 2022.
- Los Angeles Capital Management opened 138 new positions and closed 234 in Q3 2022.
- Los Angeles Capital Management's portfolio value fell 5.2% quarter-over-quarter to $19.3B.
Based on Los Angeles Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.